Eric is a Partner at Revelation Partners. He brings multiple decades of experience in healthcare as an investor and a scientist. At Revelation Partners he focuses on identifying and leading new investment opportunities with an emphasis on biopharma and medical devices.

Prior to Revelation Partners Eric was a Partner at DCVC Bio where he led investments in early-stage biotechnology companies. Previously, he was a Partner at Novo Ventures where he established and managed the firm’s public equities strategy focused on smidcap and late-stage private companies in therapeutics and medical devices. Earlier in his career Eric was a Director at Apposite Capital focused on healthcare secondaries and an Associate at Burrill & Company, a life sciences venture capital firm. Having initially trained as a structural biologist, he served as a Leukemia & Lymphoma Society Post-Doctoral Fellow.

Eric received a B.A. in Biophysics from Johns Hopkins University and a Ph.D. in Molecular Biology from Princeton University.